Results 81 to 90 of about 16,904 (296)

Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis [PDF]

open access: yes, 2018
Bronchiectasis is a disease associated with chronic progressive and irreversible dilatation of the bronchi and is characterised by chronic infection and associated inflammation.
A Fairs   +124 more
core   +2 more sources

The Aetiology of Elevated Total Serum Immunoglobulin E in Children

open access: yesActa Paediatrica, Volume 114, Issue 11, Page 2993-2999, November 2025.
ABSTRACT Aim The paucity of real‐world data on the aetiology of elevated total serum immunoglobulin E (TS‐IgE) in children afflicts families and health care systems with diagnostic uncertainty. We explored a cohort of children with TS‐IgE levels over 1000 kU/L, focusing on the prevalence of atopic and non‐atopic conditions, the aetiology of extremely ...
Aliisa Ärölä   +2 more
wiley   +1 more source

Allergic Bronchopulmonary Aspergillosis Unmasked: Case Series of Varied Pulmonary Presentations [PDF]

open access: yesIndian Journal of Respiratory Care
Allergic bronchopulmonary aspergillosis (ABPA) is a complex hypersensitivity reaction to the fungus Aspergillus fumigatus, primarily affecting individuals with asthma or cystic fibrosis (CF).
Anand R   +3 more
doaj   +1 more source

Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis [PDF]

open access: yes, 2018
An increasing incidence of allergic bronchopulmonary aspergillosis (ABPA) as a complication in patients with cystic fibrosis (CF) is reported. The objective of this retrospective case-control study was to assess potential risk factors for ABPA and for ...
Ammann, Roland   +4 more
core   +1 more source

Evidence Supporting a Role for Mammalian Chitinases in Efficacy of Caspofungin against Experimental Aspergillosis in Immunocompromised Rats [PDF]

open access: yes, 2013
Objectives:Caspofungin, currently used as salvage therapy for invasive pulmonary aspergillosis (IPA), strangely only causes morphological changes in fungal growth in vitro but does not inhibit the growth. In vivo it has good efficacy.
Bakker-Woudenberg, I.A.J.M. (Irma)   +6 more
core   +5 more sources

Molecular Signatures and Functional Pathways of Human Monocytes and Macrophages in Allergy: An EAACI AllergoOncology Scoping Review

open access: yesAllergy, Volume 80, Issue 10, Page 2710-2725, October 2025.
ABSTRACT AllergoOncology explores the intersection of allergic diseases and cancer, focusing on shared immune mechanisms. While monocytes and macrophages are extensively studied in cancer, their roles in allergic diseases remain underexplored. To address this gap, we conducted a scoping review to systematically characterize the molecular landscape and ...
Rodolfo Bianchini   +30 more
wiley   +1 more source

Asthma and aspergillosis: Which One causes another

open access: yesBiomedical and Biotechnology Research Journal, 2020
The respiratory system of the human body is always under exposure to a great number of fungal spores every day. Asexual spores of Aspergillus are the most frequent type occurring in various environments.
Roaa Noori Ali   +1 more
doaj   +1 more source

Post endodontic Aspergillosis in an immunocompetent individual [PDF]

open access: yes, 2015
Non-invasive aspergillosis in immunocompetent individuals subsequent to post endodontic treatment can involve the maxillary antrum. An early and accurate diagnosis will aid in prompt and effective treatment. A 35 year old female patient reported with a
Gupta, Shalini   +4 more
core   +2 more sources

The Changing Transplant Landscape in the Era of Elexacaftor/Tezacaftor/Ivacaftor: A Word of Caution

open access: yesClinical Transplantation, Volume 39, Issue 10, October 2025.
ABSTRACT Background Elexacaftor/tezacaftor/ivacaftor (ETI) has dramatically changed the landscape of cystic fibrosis (CF) care, including in those who require lung transplantation. The objectives of the study were to describe the cohort demographics and outcomes of primary lung transplant recipients before and after the availability of ETI.
Julie Semenchuk   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy